For CASP3, significant overexpression was observed only in the PTX, BLM, and PTX + BLM groups, with the highest Log2FC (3.07) in the PTX + BLM group (p < 0.05) compared to the baseline group. The gene discussed is CASP3; the disease is Bloom syndrome.